Potassium Chloride Solution
NDC Package 71656-021-02
Package Information
Potassium Chloride (potassium chloride oral) solution is potassium chloride oral solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. This formulation utilizes a solution delivery system. Marketed by Saptalis Pharmaceuticals, Llc, this product is identified by NDC 71656-021 and is authorized under FDA application ANDA211648.
Identification & Billing
- RxCUI: 312515 - potassium chloride 20 MEQ in 15 mL Oral Solution
- RxCUI: 312515 - potassium chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - K+ Chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - Pot Chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - potassium chloride 1.5 GM per 15 ML Oral Solution
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 71656 - Saptalis Pharmaceuticals, Llc
- 71656-021 - Potassium Chloride
- 71656-021-02 - 10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 30 mL in 1 CUP, UNIT-DOSE (71656-021-30)
- 71656-021 - Potassium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71656-021). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71656-021-02 identifies a specific commercial package of 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 30 ml in 1 cup, unit-dose (71656-021-30) of Potassium Chloride, a human prescription drug labeled by Saptalis Pharmaceuticals, Llc. This solution is formulated for oral use and contains potassium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Saptalis Pharmaceuticals, Llc on October 05, 2023. The current certification is valid through December 31, 2027.
How is this Saptalis Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71656002102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.